08.07.2018 Issue 413

Visit HealthEconomics.Com Subscribe to Newsletters  |  Contact Us  |  Forward to a Friend
Sponsored by:

This Week's HEOR Round-up
The Top Story in HEOR: Latest Headlines in HEOR:

Meeting Spotlights Health Costs, Value

Sunday, August 5

Health care costs and value were the hot topics during AcademyHealth’s Annual Research Meeting, according to a recent blog post.

Matching-Adjusted Indirect Comparisons Growing in Popularity

Article: High Deductibles Not Working

Relentless Health Value’s Richter, #HCBiz Show!’s Lee Talk Trends

ICER Reveals Potential Assessment Topics for ’19

DIA 2019 Issues Call for Abstracts

Juicing with Gary Features AiR Healthcare CEO Wainwright

Trump Administration Eyes Drug Importation

AMCP Forum Spotlights Payment, Benefit Models for High-Cost Drugs

Watson Health - Lead Research Analyst (Outcomes Research)

Watson Health - Senior SAS Programmer Analyst

Watson Health - Statistician/ Sr Statistician (HEOR/medical claims data)

Watson Health - Outcomes Researcher

Senior Principal - Health Economics

Principal - HTA

Principal, Health Economics

Principal, Pricing Market Access

Industry Spotlight

Conferences Webinars
14th Annual Publication Planning
    August 14-15, Philadelphia, Pennsylvania

6th Annual Reimbursement and Access
    August 15-16, Philadelphia, Pennsylvania

World Congress on Biosensors and Bioelectronics
    August 20-21, Chicago, Illinois

The Building Blocks of Successful Outcomes in Data-Driven Clinical Trials
    August 14

Tackling the Top 5 Barriers for Medication Adherence
    August 15

Conference of the Week Webinar of the Week Job of the Week Link of the Week

Syndicated Reports White Papers
HTA in Europe: Key Success Factors for Positive HTA Recommendations

Paying for Digital Health: Payer Insights

Benchmarking Pharma’s MSL Capabilities

Biosimilars: U.S. Payer Perspectives

KAM Metrics: Driving Efficiency, Measuring Success

Biosimilars: E.U. Payer Perspectives

How Payers Can Save an Average of $25,579 Per Patient by Eliminating Unwarranted, Non-Evidence-Based Cancer Treatment

ICER’s Reference Case for Economic Evaluations: Principles and Rationale

A Guide to Getting Started in HEOR/Market Access Medical Writing

Impact of Displaying in-EHR Patient Drug Prices With or Without Patient Savings Messages

Taking a Total View: Linking Pharmacy + Medical Drug Trends

Special Thanks to Our Partners:
      Evidera   HealthCore     University of FL   Truven
      Xcenda    OM1    Parexel   Jefferson   Dymaxium
          Precision Xtract    Pharmerit    eMax Health   Sciformix
      Evidence Partners    ICON